{"id":94,"date":"2009-10-23T15:09:46","date_gmt":"2009-10-23T19:09:46","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/researchers\/publications\/_2006\/"},"modified":"2020-04-27T15:43:59","modified_gmt":"2020-04-27T19:43:59","slug":"_2006","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/research\/publications\/archive\/_2006\/","title":{"rendered":"2006"},"content":{"rendered":"

Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V: <\/strong>Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts.<\/a> Am J Pathol. 2006 Dec; 169(6):1939-52.<\/p>\n

\u00a0<\/strong><\/p>\n

Rosenzweig M, Skinner M, Prokaeva T, Theberge R, Costello C, Drachman BN, Connors LH:<\/strong>\u00a0A new transthyretin variant Glu-61-Gly associated with cardiomyopathy.\u00a0 Amyloid: J Prot Folding Disorders, in press, 2006.<\/p>\n

\u00a0<\/strong><\/p>\n

Sanchorawala V<\/strong>: <\/strong>Light-chain (AL) amyloidosis: diagnosis and treatment<\/a>. Clin J Am Soc Nephrol. 2006 Nov; 1 (6): 1331-41.<\/p>\n

\u00a0<\/strong><\/p>\n

Sanchorawala V, Blanchard E, Seldin DC, O\u2019Hara C, Skinner M, Wright DG.<\/strong> AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes.<\/a> American Journal of Hematology 2006; 81: 692-695<\/p>\n

Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC. <\/strong>Lenalidomide and dexamethasone in the treatment of AL amyloidosis: Results of a phase II trial.<\/a>, Blood, 2006 Sep 7; [Epub ahead of print]<\/p>\n

Sawyer, D, Skinner M: <\/strong>Cardiac Amyloidosis: Shifting Our Impressions to Hopeful.<\/a>\u00a0 Curr Heart Fail Rep., 3(2): 64-71, 2006.<\/p>\n

Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Oran B, and Skinner M.<\/strong> Successful treatment of AL Amyloidosis with high dose melphalan and autologous stem cell transplantation in patients over age 65.<\/a> Blood. 2006 Dec. 1; 108(12):3945-7.<\/p>\n

\u00a0<\/strong><\/p>\n

Weichman K, Dember LD, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, and Sanchorawala V.<\/strong> Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.<\/a> BMT 2006, 38(5):339-343.<\/p>\n","protected":false},"excerpt":{"rendered":"

Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V: Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts. Am J Pathol. 2006 Dec; 169(6):1939-52. \u00a0 Rosenzweig M, Skinner M, Prokaeva T, Theberge R, Costello C, Drachman BN, Connors LH:\u00a0A new transthyretin variant Glu-61-Gly […]<\/p>\n","protected":false},"author":1963,"featured_media":0,"parent":662,"menu_order":8,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/94"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/1963"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":13,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/94\/revisions"}],"predecessor-version":[{"id":3999,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/94\/revisions\/3999"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/662"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}